MYUNGIN PHARM.CO., LTD

317450· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩43,350+2.73%

2026-08-04

Financials

Valuation Metrics

MYUNGIN PHARM.CO., LTD's Market Cap is ₩6329B. Ranked #380 of 2,436 in KR market (top 16%), #258 of 787 on KOSPI (top 33%), #42 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 18%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	632.91B KRW	KR#380/2,436 Sec#42/234
Revenue	287.25B KRW	KR#832/2,436 Sec#39/234
Net Income	81.44B KRW	KR#260/2,436 Sec#17/234
Total Assets	841.67B KRW	KR#518/2,436 Sec#29/234
Net Assets	794.38B KRW	KR#339/2,436 Sec#21/234
Value
P/E	7.77x	KR#544/2,436 Sec#24/234
P/B	0.80x	KR#1,280/2,436 Sec#75/234
P/S	2.20x	KR#1,880/2,436 Sec#108/234
EV/EBITDA	6.50x	KR#340/2,436 Sec#12/234
FCF Yield	8.14%	KR#690/2,436 Sec#33/234
Profitability
ROE	10.25%	KR#488/2,436 Sec#31/234
ROA	9.68%	KR#210/2,436 Sec#17/234
Op. Margin	32.20%	KR#42/2,436 Sec#10/234
Financial Health
Debt Ratio	105.95%	KR#366/2,436 Sec#50/234
Total Debt	0 KRW	KR—/2,436 Sec—/234
FCF	51.52B KRW	KR#285/2,436 Sec#16/234
Cash	31.79B KRW	KR#970/2,436 Sec#63/234
Current Ratio	13.93x	KR#57/2,436 Sec#18/234
Net Debt/EBITDA	-0.34x	KR#616/2,436 Sec#37/234
Dividend
Div. Yield	3.56%	KR#539/2,436 Sec#22/234
Performance
1M Return	1.52%	KR#732/2,436 Sec#64/234
From 52W High	-67.77%	KR#2,064/2,436 Sec#182/234
1Y MDD	-67.35%	KR#1,809/2,436 Sec#149/234
Trading
Volume	9,829 shares	KR#2,120/2,436 Sec#211/234
Foreign Own.	0.71%	KR—/2,436 Sec—/234
Per Share
EPS	6,594 KRW	KR#129/2,436 Sec#9/234
BPS	54,416 KRW	KR#222/2,436 Sec#14/234

Company Info

CEO 이행명

Founded 1988

HQ 경기도 화성시, KR

Website www.myunginph.co.kr

동사는 1985년 설립되어 유가증권시장에 상장한 중추신경계 치료 약물 전문기업임. 치매, 파킨슨, 뇌전증 등 신경계 약물과 조현병, 우울증, 불안 및 수면치료제 시장에서 국내 1위를 차지하고 있음. 일반의약품 이가탄F와 메이킨Q는 높은 인지도로 시장 선점 중이며, 원료합성부터 완제 의약품 생산까지 전 공정 기술력과 cGMP 기준 생산설비를 보유, 글로벌 제약사와 협력하고 있음. 명인제약는 1988년에 설립되었으며 경기도 화성시에 본사를 두고 있습니다.